143 related articles for article (PubMed ID: 1327510)
21. Viral pathogenesis in hu-PBL-SCID mice.
Mosier DE
Semin Immunol; 1996 Aug; 8(4):255-62. PubMed ID: 8883149
[TBL] [Abstract][Full Text] [Related]
22. Tumorigenesis of Epstein-Barr virus-positive epithelial cell lines derived from gastric tissues in the SCID mouse.
Murakami M; Hoshikawa Y; Satoh Y; Ito H; Tajima M; Okinaga K; Miyazawa Y; Kurata T; Sairenji T
Virology; 2000 Nov; 277(1):20-6. PubMed ID: 11062032
[TBL] [Abstract][Full Text] [Related]
23. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
24. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus lymphoblastoid cell lines from transplanted patients induce B lymphomas in SCID/hu mice: study of EBV replication.
Blanc-Brunat N; Laurin D; Vivier G; Touraine JL; Sergeant A; Garnier JL
Transplant Proc; 1995 Apr; 27(2):1776. PubMed ID: 7725498
[No Abstract] [Full Text] [Related]
26. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
Lapenta C; Spada M; Santini SM; Racca S; Dorigatti F; Poli G; Belardelli F; Alfano M
Int Immunol; 2005 Apr; 17(4):469-75. PubMed ID: 15746245
[TBL] [Abstract][Full Text] [Related]
27. Human T-cell lymphotropic virus type-I infection in the severe combined immunodeficiency mouse.
Furlan R; Salazar-Grueso EF; Martino G; Roos RP; Brambilla E; Castellano M; Cao J; Lillo F; Terreni MR; Bacellar H; Dorigatti F; Grimaldi LM
J Med Virol; 1996 Jun; 49(2):77-82. PubMed ID: 8991939
[TBL] [Abstract][Full Text] [Related]
28. SCID/human mouse model of central nervous system lymphoproliferative disease.
Bashir R; Okano M; Kleveland K; Pirrucello S; Masih A; Sanger W; Fordyce-Boyer R; Purtilo D
Lab Invest; 1991 Dec; 65(6):702-9. PubMed ID: 1684402
[TBL] [Abstract][Full Text] [Related]
29. Human immunoglobulins produced in hu-PBL-SCID mice are polyclonal early after xenotransplantation.
Tissot JD; Schneider P; Schapira M; Duchosal MA
Cell Immunol; 1996 Feb; 167(2):241-8. PubMed ID: 8603433
[TBL] [Abstract][Full Text] [Related]
30. Human-derived IgG level as an indicator for EBV-associated lymphoma model in Hu-PBL/SCID chimeras.
Tang Y; He R; Zhang Y; Liu F; Cheng A; Wu Y; Gan R
Virol J; 2011 May; 8():213. PubMed ID: 21554672
[TBL] [Abstract][Full Text] [Related]
31. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
32. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
33. Growth and spread in nude mice of Epstein-Barr virus transformed B-cells from a chronic lymphocytic leukemia patient.
Lee CL; Uniyal S; Fernandez LA; Lee SH; Ghose T
Cancer Res; 1986 May; 46(5):2497-501. PubMed ID: 3008990
[TBL] [Abstract][Full Text] [Related]
34. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-infected marmoset cells transfected with c-myc do not form lymphomas in mice with severe combined immunodeficiency.
Salimi B; O'Gorman MR; Variakojis D; Bendet M; Newman M; Poupko E; Katz BZ
Mol Genet Metab; 1998 Jul; 64(3):205-12. PubMed ID: 9719630
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
37. Transfer of a functional human immune system to mice with severe combined immunodeficiency.
Mosier DE; Gulizia RJ; Baird SM; Wilson DB
Nature; 1988 Sep; 335(6187):256-9. PubMed ID: 2970594
[TBL] [Abstract][Full Text] [Related]
38. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus-infected marmoset cells do not form lymphomas in mice with severe combined immunodeficiency.
Katz BZ; Salimi B; Saini U; McNamara JG; Eisen R
Pediatr Res; 1994 Oct; 36(4):456-60. PubMed ID: 7816520
[TBL] [Abstract][Full Text] [Related]
40. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.
Dirmeier U; Neuhierl B; Kilger E; Reisbach G; Sandberg ML; Hammerschmidt W
Cancer Res; 2003 Jun; 63(11):2982-9. PubMed ID: 12782607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]